Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model
{{output}}
Introduction: Drug risk assessment to ventricular conduction typically involves measuring functional inhibition of the cardiac sodium channel (Nav1.5) followed by nonclinical in vivo assessment of prolongation of the electrocardi... ...
